Announcements Trials
Browse Landscape

Phase

Phase 1 4

Status

Recruiting 2Active not recruiting 2

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 105Lymphoid 15Other hematologic neoplasm 13Thoracic 11Other solid neoplasm 6Gynecologic 5Tumor-Agnostic 4Head & Neck 4Genitourinary 4Sarcoma 2Myeloid 2Dermatologic 2CNS 2Breast 2Endocrine 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Squamous Cell Carcinoma of Head and Neck 2Colorectal Neoplasms 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Spinocerebellar Degenerations 1Ovarian Neoplasms 1Neoplasms 1Melanoma 1Head and Neck Neoplasms 1Glioma 1Esophageal Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Cisplatin 87pembrolizumab 82Magnetic Resonance Spectroscopy 46Radiotherapy, Intensity-Modulated 39Carboplatin 39Specimen Handling 37Radiotherapy 35Cetuximab 33Nivolumab 29Paclitaxel 25Platinum 22Radiation 21Gemcitabine 21Docetaxel 21Biopsy 211,2-diaminocyclohexaneplatinum II citrate 20Surveys and Questionnaires 15Fluorouracil 15toripalimab 13Taxes 11Standard of Care 11cemiplimab 10Surgical Procedures, Operative 10X-Rays 9Ipilimumab 9Drug Therapy 9atezolizumab 8Radiosurgery 8Immunoglobulin G 8Cyclophosphamide 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Leucovorin × Head & Neck × 90 days × Clear all
NCT05355701 2026-05-14

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

Pfizer

Phase 1 Recruiting
267 enrolled
CNSDermatologicHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Glioma, Melanoma, Thyroid Neoplasms

NCT05647122 2026-05-11

EGRET

AstraZeneca

Phase 1 Recruiting
403 enrolled
GastrointestinalHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Neoplasms, Colorectal Neoplasms

NCT06544655 2026-04-17

A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors

Bristol-Myers Squibb

Phase 1 Active not recruiting
213 enrolled
GastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Spinocerebellar Degenerations, Colorectal Neoplasms

NCT05891171 2026-03-31

ARC-25

Arcus Biosciences, Inc.

Phase 1 Active not recruiting
40 enrolled
BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡